Results 161 to 170 of about 355,625 (242)

Sisk et al. Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: Role of comorbid conditions and race. Ann Intern Med 2003 17;138:960-8 [PDF]

, 2004
Burton Zweiman, Marc E. Rothenberg
openalex   +1 more source

Pneumococcal serotypes and their association with death risk in invasive pneumococcal disease: a systematic review and meta-analysis

Frontiers in Medicine
BackgroundStreptococcus pneumoniae and its infections are a global public health concern. Invasive pneumococcal disease accounts for significant mortality in the aged and immunocompromised. Over 100 unique capsular serotypes have been identified, with 80–
Samuel Darkwah, Namwin S. Somda, Samiratu Mahazu, Eric S. Donkor   +3 more
doaj   +1 more source

Invasive Pneumococcal Disease in Children: Changing Serotypes and Clinical Expression of Disease [PDF]

, 2005
Esther Calbo, Javier Garau
openalex   +1 more source

High mortality of invasive pneumococcal disease compared with meningococcal disease in critically ill children [PDF]

, 2005
Kentigern Thorburn, Nia Taylor, Lucía López‐Rodríguez, Michael T. Ashworth, Miguel A. de la Cal, H. K. F. van Saene   +5 more
openalex   +1 more source

Characterization of the role that bacterial surface polysaccharide poly N-acetyl glucosamine plays in nonvaccine serotypes of streptococcus pneumoniae colonization and pathogenicity [PDF]

, 2016
Poly N-acetyl glucosamine is a cell surface polysaccharide that has been characterized in Staphylococcus epidermidis and Staphylococcus aureus as involved in biofilm formation and implicated in virulence.
Jiang, Fanny
core   +1 more source

Occurrence of invasive pneumococcal disease and number of excess cases due to influenza [PDF]

, 2006
Katarzyna Grabowska, Liselotte Diaz Högberg, Pasi Penttinen, Åke Svensson, Karl Ekdahl   +4 more
openalex   +1 more source

Burden of paediatric invasive pneumococcal disease in Europe, 2005 [PDF]

, 2006
E. David G. McIntosh, Bernard Fritzell, M A Fletcher   +2 more
openalex   +1 more source

Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine [PDF]

, 2006
Ignacio Obando, Luis Alberto Rodríguez Arroyo, David Sánchez-Tatay, David Tarragó, David Moreno, William P. Hausdorff, Angela B. Brueggemann   +6 more
openalex   +1 more source

Comparison of secular trends in pneumococcal serotypes causing invasive disease in Denver, Colorado (1971–2004) and serotype coverage by marketed pneumococcal vaccines [PDF]

, 2006
Deniz Akduman, Josephine M. Ehret, Franklyn N. Judson   +2 more
openalex   +1 more source

Invasive pneumococcal disease caused by non-vaccine Streptococcus pneumoniae serotype 24B in an immunocompetent child

Radiology Case Reports
Invasive pneumococcal disease typically occurs in immunocompromised patients, although some vaccine strains of Streptococcus pneumoniae have been reported to cause invasive pneumococcal disease in immunocompetent vaccine recipients.
Naotaka Tamai, MD, Masayoshi Shinjoh, MD, PhD, Hiroyuki Oikawa, MD, Riku Hamada, MD, Tomohiro Morio, MD, PhD, Goro Koinuma, MD, Takao Takahashi, MD, PhD   +6 more
doaj